Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.

Jul 16, 2021 by in CARDIOLOGY Comments Off on Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.

American physicians are now treating dyslipidemia according to a fifth iteration of national guidelines for the use of lipid-lowering therapies . These guidelines are developed with considerable care and deliberation…

read more

Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

Jul 16, 2021 by in CARDIOLOGY Comments Off on Geographic variations in lipid-lowering therapy utilization, LDL-C levels, and proportion retrospectively meeting the ACC/AHA very high-risk criteria in a real-world population of patients with major atherosclerotic cardiovascular disease events in the United States

Abstract Objective We assessed national- and state-level geographic variations among patients with a history of ≥1 major atherosclerotic cardiovascular disease (ASCVD) event in: (1) the proportion of patients with retrospectively…

read more

Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement

Jul 16, 2021 by in CARDIOLOGY Comments Off on Optimizing sodium-glucose co-transporter 2 inhibitor use in patients with heart failure with reduced ejection fraction: A collaborative clinical practice statement

Highlights • HFrEF is a debilitating disease with substantial morbidity, mortality, and costs. • SGLT2i reduce adverse cardiovascular (including HF) and renal events. • SGLT2i have ushered in a new…

read more

Effect of government-issued state of emergency and reopening orders on cardiovascular hospitalizations during the COVID-19 pandemic

Jul 16, 2021 by in CARDIOLOGY Comments Off on Effect of government-issued state of emergency and reopening orders on cardiovascular hospitalizations during the COVID-19 pandemic

Highlights • Acute cardiovascular hospitalizations in NC declined after the state of emergency order. • Declines in rates were similar in both urban and rural counties, and older individuals experienced…

read more

Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective

Jul 16, 2021 by in CARDIOLOGY Comments Off on Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective

Summary Introduction Familial hypercholesterolaemia (FH) is a common, heritable and preventable cause of premature coronary artery disease, with significant potential for positive impact on public health and healthcare savings. New…

read more

Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease

Jul 16, 2021 by in CARDIOLOGY Comments Off on Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease

Abstract Background and aims Chronic inflammation is associated with premature atherosclerotic cardiovascular disease (ASCVD). We studied the prevalence of cardiovascular risk factors (CRFs) amongst individuals with IBD who have not…

read more
Premium Wordpress Themes by UFO Themes